Clinical Trial Update: A Study to Evaluate the Long-term Safety and Efficacy of Deucravacitinib in Participants With Crohn's Disease or Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating the long-term safety and efficacy of deucravacitinib in participants with Crohn's disease or ulcerative colitis, with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• Deucravacitinib (deucravacitinib)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Crohn Disease, Ulcerative Colitis | Phase 2 | Status: COMPLETED | Results posted: 2024-09-24